Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Quality of reported income
3Y CAGR
+3.6%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.92 | +18.6% |
| 2024 | 0.78 | -8.7% |
| 2023 | 0.85 | +2.7% |
| 2022 | 0.83 | -8.4% |
| 2021 | 0.91 | - |